APA (7th ed.) Citation

Ang, D., Koo, S. H., Chan, Y. H., Tan, T. Y., Soon, G. H., Tan, C. K., . . . Ang, T. L. (2022). Clinical trial: Seven‐day vonoprazan‐ versus 14‐day proton pump inhibitor‐based triple therapy for first‐line Helicobacter pylori eradication. Alimentary Pharmacology & Therapeutics, 56(3), 436. https://doi.org/10.1111/apt.17070

Chicago Style (17th ed.) Citation

Ang, Daphne, et al. "Clinical Trial: Seven‐day Vonoprazan‐ Versus 14‐day Proton Pump Inhibitor‐based Triple Therapy for First‐line Helicobacter Pylori Eradication." Alimentary Pharmacology & Therapeutics 56, no. 3 (2022): 436. https://doi.org/10.1111/apt.17070.

MLA (9th ed.) Citation

Ang, Daphne, et al. "Clinical Trial: Seven‐day Vonoprazan‐ Versus 14‐day Proton Pump Inhibitor‐based Triple Therapy for First‐line Helicobacter Pylori Eradication." Alimentary Pharmacology & Therapeutics, vol. 56, no. 3, 2022, p. 436, https://doi.org/10.1111/apt.17070.